Carregant...

The Clinical Efficacy of Imiglucerase versus Eliglustat in Patients with Gaucher's Disease Type 1: A Systematic Review

Gaucher's disease (GD) is one of the most common lysosomal diseases in humans. It results from β-glucosidase deficiency and leads to necrosis, especially in macrophages with the accumulation of glucosylceramidase in cells. Most of the deleterious effects of the disease are seen in the liver, sp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Res Pharm Pract
Autors principals: Nabizadeh, Azita, Amani, Bahman, Kadivar, Maliheh, Toroski, Mahdi, Asl, Akbar Abdollahi, Bayazidi, Yahya, Mojahedian, Mahdi, Davari, Majid
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications & Media Pvt Ltd 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6298139/
https://ncbi.nlm.nih.gov/pubmed/30622983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/jrpp.JRPP_18_24
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!